← Leaderboards
Joanna B Kitlinska
Georgetown University
$3,902,520
Attributed
$4,103,077
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $553.6K · FY2006–24$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,103,077 · 7
By mechanism
R01$3,087,074 · 2
R21$773,149 · 2
R03$230,767 · 2
M01$12,087 · 1
Top collaborators
- Stella Alimperti1 shared
Most similar at Georgetown University
Same institution · by research overlap
- Moshe Levi$17,675,566
- Kathryn L Sandberg$21,619,723
- Regina M Day$1,379,469
- Hong Ji$598,413
- Aruna R Natarajan$147,020
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorNeoplastic CellNeuropeptide YProteinsCellsPathway InteractionsNeoplasm MetastasisNeuroblastomaFutureMediator Of Activation ProteinOutcome ForecastNeurotransmittersReceptorPhenotypePediatric NeoplasmNeuronsXenograft ProcedureIn VitroHypoxiaIn VivoPeptidesEndothelial CellsAngiogenesisEnvironment
Grant awards (17)
3D bioengineered microfluidic platform for research on Ewing sarcoma bone metastasis$401,115
R21 · FY2024 · CA · contact PI
Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor$345,034
R01 · FY2019 · CA · contact PI
Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor$352,710
R01 · FY2018 · CA · contact PI
Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor$348,597
R01 · FY2017 · CA · contact PI
Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor$351,644
R01 · FY2016 · CA · contact PI
Prenatal stress and neuroblastoma development - is there a link?$169,106
R21 · FY2016 · CA · contact PI
Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor$350,628
R01 · FY2015 · CA · contact PI
Prenatal stress and neuroblastoma development - is there a link?$202,928
R21 · FY2015 · CA · contact PI
In vivo model of hypoxia in Ewing Sarcoma$75,417
R03 · FY2014 · CA · contact PI
In vivo model of hypoxia in Ewing Sarcoma$77,750
R03 · FY2013 · CA · contact PI
Neuropeptide Y in neuroblastoma: growth, angiogenesis and future therapeutics.$267,492
R01 · FY2010 · CA · contact PI
Neuropeptide Y in neuroblastoma: growth, angiogenesis and future therapeutics.$267,492
R01 · FY2009 · CA · contact PI
BANK OF NORMAL SERUM AND PLASMA FROM HEALTHY CHILDREN$12,087
M01 · FY2009 · RR · contact PI
Neuropeptide Y in neuroblastoma: growth, angiogenesis and future therapeutics.$267,492
R01 · FY2008 · CA · contact PI
Neuropeptide Y in neuroblastoma: growth, angiogenesis and future therapeutics.$265,208
R01 · FY2007 · CA · contact PI
Neuropeptide Y in neuroblastoma: growth, angiogenesis and future therapeutics.$270,777
R01 · FY2006 · CA · contact PI
Aging, Angiogenesis, and the Neuropeptide Y (NPY) System$77,600
R03 · FY2002 · AG